Startups
Starting as the biomedical business of Takara Shuzo Co. Ltd. – a fermentation and beverage company founded in 1925 (now Takara Holdings Inc.) – Takara Bio introduced the first domestically-produced restriction enzymes to the Japanese market in 1979. With over 40 years of continuous experience in providing innovative solutions to life science researchers, Takara Bio maintains a strong intellectual property position and offers a broad array of product lines in PCR, Molecular Biology, enzymes, antibodies, cell biology, and protein research. Takara Bio products are sold in North and South America through Clontech Laboratories.
Overview
Location
Sweden, Göteborgs Stad
Employees
201-500
Founded date
1995
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 27, 2026 | Preimplantation Genetic Diagnosis Market to Reach USD 1,135.0 Million by 2030 | The global Preimplantation Genetic Diagnosis Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. Market growth is being driven by the increasing ... |
| Apr 24, 2026 | DSS Imagetech Marks 'Microscopy Month' with Pan India Webinar Series | New Delhi, Delhi, India DSS Imagetech, a market leader in Molecular Diagnostics, Life Sciences, and Biotechnology is hosting a series of expert-led webinars commemorating World Microscopy Day starting April 13 - World Microscopy Day. As par... |
| Sep 15, 2025 | The Scientist Unveils the 2025 Top Innovations Award Winners | The Scientist Top 10 Innovations of 2025 Fourteen breakthrough technologies are recognized across biotechnology, healthcare, lab tools, and startup innovations. WILMINGTON, Del., Sept. 15, 2025 /PRNewswire-PRWeb/ -- The Scientist proudly an... |
| Apr 23, 2024 | Capitainer Recruits New Sales and Distribution Manager to Strengthen the Sales Organization | Capitainer Recruits New Sales and Distribution Manager to Strengthen the Sales Organization Tue, Apr 23, 2024 07:52 CET Report this content Capitainer, a leading Swedish medtech company that specializes in user-friendly self-sampling soluti... |
| Oct 20, 2022 | TATAA Biocenter and pivotal research project will establish Sweden as a major leader in ATMPs | TATAA Biocenter and pivotal research project will establish Sweden as a major leader in ATMPs Thu, Oct 20, 2022 14:54 CET Report this content As part of a 320M SEK investment program in biological therapies, one research project will play a... |
| Aug 10, 2021 | Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet? | |
| О чем вы много думали, но боялись узнать #1 — аденовирусная векторная вакцина | Доброго дня уважаемые хабровчане. Я решил освещать некоторые вопросы в сфере медицины в формате мини-текстов по определенным темам. В последнюю неделю самой горячей темой была вакцинация в России, а именно вакцина Спутник V (Gam-COVID-Vac).... |
Reviews 0
FAQ about TakaraBioUSA
When was TakaraBioUSA founded?
TakaraBioUSA was founded in 1995.
What has the press written about TakaraBioUSA?
Parsers VC has collected 8 articles mentioning TakaraBioUSA, among them “Preimplantation Genetic Diagnosis Market to Reach USD 1,135.0 Million by 2030” (Aug 27, 2026) and “DSS Imagetech Marks 'Microscopy Month' with Pan India Webinar Series” (Apr 24, 2026).
Is TakaraBioUSA still active?
Yes, TakaraBioUSA is active; its latest activity on Parsers VC dates from Sep 15, 2026.